Human Immunodeficiency Virus Type 1 Protease Cleavage Site Mutations Associated with Protease Inhibitor Cross-Resistance Selected by Indinavir, Ritonavir, and/or Saquinavir

We examined the prevalence of cleavage site mutations, both within and outside the gag region, in 28 protease inhibitor (PI) cross-resistant patients treated with indinavir, ritonavir, and/or saquinavir compared to control patients treated with reverse transcriptase inhibitors. Three human immunodef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Côté, Hélène C. F., Brumme, Zabrina L., Harrigan, P. Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2001
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC113954/
https://ncbi.nlm.nih.gov/pubmed/11134271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.75.2.589-594.2001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados